Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Report

China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Market Research Report 2023-2029

  • POSTDATE：Oct 11, 2023
  • PAGES：199
  • REPORT CODE：GMM1845760
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • CARSGEN Therapeutics?Ltd

    • Kite Pharma

    • Guangzhou Xiangxue Pharmaceutical

    • Bristol Myers Squibb

    • Legend Biotech

    • Sorrento Therapeutics

    • Juno Therapeutics

    • Carina Biotech

    • Novartis

    By Type:

    • Allogeneic CAR T-Cells

    • Autologous CAR T-Cells

    By Application:

    • Diagnostic Center

    • Others

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Overview 2018-2029

    • 1.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Development Overview

    • 1.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Development History

    • 1.3 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Market Size (2018-2029)

    • 1.4 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis by Type from Production Side

      • 1.4.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of Allogeneic CAR T-Cells (2018-2029)

      • 1.4.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of Autologous CAR T-Cells (2018-2029)

    • 1.5 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis by Application from Consumption End

      • 1.5.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Diagnostic Center (2018-2029)

      • 1.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis by Region

      • 1.6.1 North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status and Competition Analysis in 2023

      • 2.2.3 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Development

    Chapter 3 Chimeric Antigen Receptor (CAR) T-Cell ImmunotherapyIndustry Chain Analysis

    • 3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Chain

    • 3.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market

    • 3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market

    Chapter 4 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Type

    • 4.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume and Growth Rate, by Type

      • 4.5.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume and Growth Rate of Allogeneic CAR T-Cells

      • 4.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume and Growth Rate of Autologous CAR T-Cells

    Chapter 5 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate, by Application

      • 5.5.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate of Diagnostic Center

      • 5.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate of Others

      • 5.5.3 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate of Hospital

    Chapter 6 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Region

    • 6.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume and Production Value, by Region

    • 6.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume and Sales Value, by Region

    Chapter 7 North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis

    • 7.1 North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Type

    • 7.2 North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Application

    Chapter 8 Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis

    • 8.1 Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Type

    • 8.2 Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Application

    Chapter 9 South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis

    • 9.1 South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Type

    • 9.2 South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Application

    Chapter 10 East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis

    • 10.1 East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Type

    • 10.2 East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Application

    Chapter 11 Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis

    • 11.1 Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Type

    • 11.2 Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Application

    Chapter 12 Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis

    • 12.1 Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Type

    • 12.2 Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Application

    Chapter 13 Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis

    • 13.1 Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Type

    • 13.2 Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 CARSGEN Therapeutics?Ltd

        • 14.1.1 CARSGEN Therapeutics?Ltd Company Profile

        • 14.1.2 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Kite Pharma

        • 14.2.1 Kite Pharma Company Profile

        • 14.2.2 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Guangzhou Xiangxue Pharmaceutical

        • 14.3.1 Guangzhou Xiangxue Pharmaceutical Company Profile

        • 14.3.2 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bristol Myers Squibb

        • 14.4.1 Bristol Myers Squibb Company Profile

        • 14.4.2 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Legend Biotech

        • 14.5.1 Legend Biotech Company Profile

        • 14.5.2 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sorrento Therapeutics

        • 14.6.1 Sorrento Therapeutics Company Profile

        • 14.6.2 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Juno Therapeutics

        • 14.7.1 Juno Therapeutics Company Profile

        • 14.7.2 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Carina Biotech

        • 14.8.1 Carina Biotech Company Profile

        • 14.8.2 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Novartis

        • 14.9.1 Novartis Company Profile

        • 14.9.2 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Research Conclusions

    • 15.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Market Size (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of Allogeneic CAR T-Cells (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of Autologous CAR T-Cells (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Diagnostic Center (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029

    • Figure Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type in 2018

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type in 2023

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume and Growth Rate of Allogeneic CAR T-Cells (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume and Growth Rate of Autologous CAR T-Cells (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application in 2018

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application in 2023

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Total Market Size and Growth Rate from Consumption End

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate of Diagnostic Center (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate of Others (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Region (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Value by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Value Share by Region (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Value Share by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Region (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Value by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Value Share by Region (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Value Share by Region (2018-2023)

    • Table North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure North China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Central China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure South China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure East China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume by Type (2018-2023)

    • Table Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Production Volume Share by Type (2018-2023)

    • Table Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume by Application (2018-2023)

    • Table Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)

    • Table CARSGEN Therapeutics?Ltd Company Profile

    • Table CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Kite Pharma Company Profile

    • Table Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Guangzhou Xiangxue Pharmaceutical Company Profile

    • Table Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Bristol Myers Squibb Company Profile

    • Table Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Legend Biotech Company Profile

    • Table Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Sorrento Therapeutics Company Profile

    • Table Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Juno Therapeutics Company Profile

    • Table Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Carina Biotech Company Profile

    • Table Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US